Adjuvant therapy for pancreatic cancer

Swiss Surgery

Volumn 6, Issue 5, 2000, Pages 289-295

  Ghaneh, P ^a   Slavin, J ^a   Sutton, R ^a   Neoptolemos, J P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adenocarcinoma; Chemotherapy; Pancreas; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C;

ADULT; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; TREATMENT OUTCOME; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MORTALITY; PANCREAS TUMOR; RANDOMIZED CONTROLLED TRIAL; REVIEW; SURVIVAL RATE;

ADENOCARCINOMA; CHEMOTHERAPY, ADJUVANT; HUMANS; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033626489     PISSN: 10239332     EISSN: None     Source Type: Journal    
DOI: 10.1024/1023-9332.6.5.289     Document Type: Conference Paper

References (71)

1. Incidence treatment and survival in 13560 patients with pancreatic cancer: An epidemiological study in the West Midlands
2. Population based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals 1989-1994
3. Survival after pancreatoduodenectomy: 118 Consecutive resections without an operative mortality
4. Pancreatoduodenectomy for cancer of the head of the pancreas in 201 patients
5. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units
6. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head
7. Long term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?
8. Results of extensive surgery for pancreatic carcinoma. Cancer
9. Survival after resection for ductal adenocarcinoma of the pancreas
10. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma treated by pancreatoduodenectomy plus extended lymphadenectomy: Surgery
11. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy. In the surgical treatment of adenocarcinoma of the head of the pancreas: A multicentre, prospective, randomized study. Lymphadenectomy study group
12. Pancreas cancer resection outcome in American university centers in 1989-1990
13. Pancreatic cancer treatment in the United States Veteran from 1987-1991 - Effect of tumour stage on survival
14. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas
15. Prognostic factors for survival after pancreatic duodenectomy for patients with carcinoma of the pancreatic head region
16. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy
17. Adjuvant therapy of resected adenocarcinoma of the pancreas
18. Recurrence of exocrine pancreatic cancer - Local or hepatic?
19. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer
20. Recurrence after resection for ductal adenocarcinoma of the pancreas
21. Patterns of failure after curative resection of pancreatic carcinoma
22. The time of occurrence of liver metastasis in carcinoma of the pancreas
23. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging
24. Review article: Current treatment and optimal patient management in pancreatic cancer
25. Chemotherapy in pancreatic cancer: Results of a controlled prospective randomised multicentre trial
26. A phase III trial on the therapy of advanced pancreatic cancer
27. Randomized study of 5-FU and CCNU in pancreatic cancer: Report of the veterans administration surgical adjuvant cancer chemotherapy study group
28. Chemotherapy prolongs survival in operable pancreatic carcinoma
29. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
30. A randomised trial of gemcitabine versus 5-FU as first line therapy in advanced pancreatic cancer
31. Severe nonhaematological toxicity after treatment with gemcitabine
32. External beam plus intraoperative irridiation for gastrointestinal cancers
33. Radiation therapy for pancreatic cancer - A retrospective study of the University of Louisville experience
34. Intraoperative and external beam irradiation ± 5FU for locally advanced pancreatic cancer
35. High dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer
36. Preoperative chemoradiation for adenocarcinoma of the pancreas: Excessive toxicity of prophylactic hepatic irradiation
37. Therapy of locally unresectable pancreatic carcinoma: A randomised comparison of high dose (6000 rads) radiation alone, moderate dose radiation (400 rads + 5-flourouracil), and high dose radiation + 5-flourouracil
38. Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: Results of a feasibility study
39. A randomised trial of intraoperative radiation therapy (IORT) vs IORT plus chemotherapy (Mtx-5FU) for adenocarcinoma of the pancreas
40. Intra-arterial chemotherapy with MMC, CDDP and 5-FU for non-resectable pancreatic cancer - A phase II study
41. Regional chemotherapy for inoperable pancreatic carcinoma
42. Is the long term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head?
43. Preoperative chemoradiation pancreaticoduodenectomy and intraoperative radiation therapy for adenocarcinoma of the pancreatic head
44. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas
45. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An eastern cooperative oncology group study
46. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum
47. Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomised pilot study
48. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - Results of a controlled, prospective, randomised multicentre study
49. Results of resection for cancer of the exocrine pancreas: A study from the French Association of Surgery
50. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy correlations of a clinical trial
51. Adjuvant radiation therapy for pancreatic cancer: A 15 year experience
52. Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer
53. Results of surgery and adjuvant radiotherapy for pancreatic cancer
54. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III trial of the EORTC gastrointestinal tract cancer cooperative group
55. Extended radical resection of cancer of the pancreas with intraoperative radiotherapy
56. Effectiveness of multimodality treatment for resectable pancreatic cancer
57. Liver perfusion chemotherapy via both hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas
58. Modern surgical treatment of pancreatic cancer
59. Palliative and adjuvant regional chemotherapy in pancreatic cancer
60. Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: Significant reduction in occurrence of liver metastasis
61. Regional treatment of advanced nonresectable and of resected pancreatic cancer via celiac axis infusion. First results of a single institution study
62. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection
63. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
64. Long term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5 year survivors
65. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival: A prospective, single institution experience
66. Adjuvant radiotherapy and follow on chemotherapy in patients with pancreatic cancer: Results of the UK Pancreatic Cancer Study Group (UKPACA-1)
67. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels
68. Progress report: A randomised multicentre European study comparing adjuvant radiotherapy, six months chemotherapy and combination therapy versus no adjuvant treatment in resectable pancreatic cancer
69. ESPAC-1 interim results: A European randomised study to assess the roles of adjuvant chemotherapy (5FU + folinic acid) and adjuvant chemoradiation (40 gy + 5FU) in resectable pancreatic cancer